The Influence of Exercise on the Insulin-like Growth Factor Axis in Oncology: Physiological Basis, Current, and Future Perspectives
Overview
Oncology
Public Health
Affiliations
Exercise and physical activity have been shown to reduce the risk of many common cancers and strongly influence tumor biology. A cause-effect mechanism explaining this relationship is dependent on cellular pathways that can influence tumor growth and are exercise responsive. The insulin-like growth factor (IGF) axis is reported to promote the development and progression of carcinomas through cellular signaling in cancerous tissues. This review summarizes the physiologic basis of the role of the IGF axis in oncology and the influence of exercise on this process. We examined the effects of exercise prescription on the IGF axis in cancer survivors by evaluating the current scope of the literature. The current research demonstrates a remarkable heterogeneity and inconsistency in the responses of the IGF axis to exercise in breast, prostate, and colorectal cancer survivors. Finally, this review presents an in-depth exploration of the physiologic basis and mechanistic underpinnings of the seemingly disparate relationship between exercise and the IGF axis in oncology. Although there is currently insufficient evidence to categorize the effects of exercise prescription on the IGF axis in cancer survivors, the inconsistency of results suggests a multifaceted relationship, the complexities of which are considered in this review.
Hu L, Tang H, Xie Z, Yi H, Feng L, Zhou P Front Microbiol. 2025; 16:1510354.
PMID: 39935644 PMC: 11813218. DOI: 10.3389/fmicb.2025.1510354.
Nasir Y, Hoseinipouya M, Eshaghi H, Rahimi M BMC Womens Health. 2024; 24(1):396.
PMID: 38987734 PMC: 11234722. DOI: 10.1186/s12905-024-03240-7.
Kyun S, Kim J, Hwang D, Jang I, Park H, Lim K Physiol Rep. 2024; 12(4):e15952.
PMID: 38383135 PMC: 10881281. DOI: 10.14814/phy2.15952.
Exercise as a Promising Agent against Cancer: Evaluating Its Anti-Cancer Molecular Mechanisms.
Spanoudaki M, Giaginis C, Karafyllaki D, Papadopoulos K, Solovos E, Antasouras G Cancers (Basel). 2023; 15(21).
PMID: 37958310 PMC: 10648074. DOI: 10.3390/cancers15215135.
Zhou Y, Jia N, Ding M, Yuan K BMC Womens Health. 2022; 22(1):507.
PMID: 36482346 PMC: 9730577. DOI: 10.1186/s12905-022-02058-5.